Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

Qi Biodesign has already achieved significant milestones in product development, including receiving two biosafety certificates for gene-edited plants (high oleic acid soybean and powdery mildew disease-resistant wheat) by the China Ministry of Agriculture and Rural Affairs and securing an exemption for a gene-edited product (high oleic acid soybean) from the US Department of Agriculture. More gene-edited traits including yield enhancements, herbicide tolerance and quality improvements are advancing through regulatory pipelines. Qi Biodesign's plant breeding innovations advance the application of gene editing in agriculture, contributing to food security and sustainable developments.
Comunicato Precedente

next
Comunicato Successivo

next

Qi Biodesign has already achieved significant milestones in product development, including receiving two biosafety certificates for gene-edited plants (high oleic acid soybean and powdery mildew disease-resistant wheat) by the China Ministry of Agriculture and Rural Affairs and securing an exemption for a gene-edited product (high oleic acid soybean) from the US Department of Agriculture. More gene-edited traits including yield enhancements, herbicide tolerance and quality improvements are advancing through regulatory pipelines. Qi Biodesign's plant breeding innovations advance the application of gene editing in agriculture, contributing to food security and sustainable developments.

The newly secured funding will be used to enhance Qi Biodesign's R&D capabilities, advance its proprietary SEEDIT™ platform, support its product development and build commercialization platforms to streamline and speed up the transition from research to market.

For more information, visit  http://www.qi-biodesign.com

CONTACT: Yihui Jiang, [email protected] 

Cision View original content:https://www.prnewswire.co.uk/news-releases/qi-biodesign-completes-75-million-in-total-funding-to-drive-genome-editing-innovations-302324636.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;